Drug recall · February 20, 2019
CIDOFOVIR DIHYDRATE recall
Why: CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CIDOFOVIR DIHYDRATE, (Non-Sterile, For Manufacturing Use), 10g, Rx only, ALP PHARM BEIJING CO., LTD, 12-2-620, Jia 69, Fushi Rd., Haidian, Beijing 100049, China. Batch Number JD-BP-37-20150801
- Lots / codes
Lot number: JD-BP-37-20150801
- Quantity
- 205 grams
- Company
- LGM Pharma LLC, Erlanger, KY
- Distribution
- Distributed to MS and Spain
- Initiated
- December 18, 2018 · Voluntary: Firm initiated
- Classified
- February 11, 2019
- Reported
- February 20, 2019
- Ended
- June 9, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cidofovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.